Table 1.
Clinical and laboratory comparison between patients with CVID and XLA
CVID N = 749 |
XLA N = 320 |
P value* | |
---|---|---|---|
Sex (male) | 322 (43.0) | 320 (100.0) | < 0.001 |
Age at last visit | 39.50 [24.90, 50.30] | 17.40 [8.43, 28.25] | < 0.001 |
Age of symptom onset | 16.00 [6.00, 30.00] | 1.00 [0.50, 2.15] | < 0.001 |
Age of diagnosis | 29.90 [15.20, 42.70] | 2.40 [1.00, 5.60] | < 0.001 |
CD4 | 664.00 [470.00, 927.00] | 1576.50 [1120.00, 2426.75] | < 0.001 |
CD8 | 390.00 [246.50, 681.00] | 795.84 [484.56, 1241.10] | < 0.001 |
CD19 | 176.00 [80.25, 309.25] | 0.00 [0.00, 13.00] | < 0.001 |
Pre-diagnostic IgG | 353 [186–514] | 65 [25.5–325] | 0.015 |
IgA | 9.99 [6.64, 31.00] | 6.66 [0.99, 8.14] | < 0.001 |
IgM | 23.00 [10.99, 44.00] | 10.00 [4.99, 22.00] | < 0.001 |
Chi-square test for categorical variables and Mann-Whitney test for continuous variables
Continuous variables were summarized as median [IQR] and categorical variables were summarized as counts (percentage)